Literature DB >> 16224937

The importance of tight glycemic control.

John E Gerich1.   

Abstract

Macrovascular complications of diabetes are the leading cause of morbidity and mortality in patients with diabetes and may begin well before diabetes is diagnosed. The precise mechanism of how postprandial hyperglycemia contributes to the pathogenesis of cardiovascular disease is not fully known but may be a result of direct effects on the vasculature. Several epidemiologic studies have suggested that increased glycemic exposure, especially postchallenge or postprandial hyperglycemia, is an independent risk factor for macrovascular disease with no apparent upper or lower threshold. Evidence is emerging that this association is also present in the prediabetic and nondiabetic states. In fact, therapies targeting postprandial hyperglycemia have shown reductions in cardiovascular events in patients with impaired glucose tolerance. Meal-related self-monitoring of blood glucose can inform patients and their healthcare providers about postprandial glycemic excursions so that diet, exercise, or medications can be adjusted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16224937     DOI: 10.1016/j.amjmed.2005.07.051

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

1.  Oral Azelaic Acid Ester Decreases Markers of Insulin Resistance in Overweight Human Male Subjects.

Authors:  Robert T Streeper; Elzbieta Izbicka; Christopher Louden
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Self-monitoring of blood glucose before and after Medicare expansion among Medicare beneficiaries with diabetes who do not use insulin.

Authors:  Rui Li; Ping Zhang; K M Venkat Narayan
Journal:  Am J Public Health       Date:  2008-01-02       Impact factor: 9.308

Review 3.  Impact of HbA1c Testing at Point of Care on Diabetes Management.

Authors:  Oliver Schnell; J Benjamin Crocker; Jianping Weng
Journal:  J Diabetes Sci Technol       Date:  2016-11-27

4.  Altered disease course after initiation of self-monitoring of blood glucose in noninsulin-treated type 2 diabetes (ROSSO 3).

Authors:  Hubert Kolb; Berthold Schneider; Lutz Heinemann; Volker Lodwig; Werner A Scherbaum; Stephan Martin
Journal:  J Diabetes Sci Technol       Date:  2007-07

5.  Psychological factors account for variation in metabolic control and perceived quality of life among people with type 2 diabetes in New Zealand.

Authors:  C A M Paddison; F M Alpass; C V Stephens
Journal:  Int J Behav Med       Date:  2008

6.  A Feedforward-Feedback Glucose Control Strategy for Type 1 Diabetes Mellitus.

Authors:  Gianni Marchetti; Massimiliano Barolo; Lois Jovanovič; Howard Zisser; Dale E Seborg
Journal:  J Process Control       Date:  2008-02       Impact factor: 3.666

Review 7.  Gut-Based Strategies to Reduce Postprandial Glycaemia in Type 2 Diabetes.

Authors:  Md Kamruzzaman; Michael Horowitz; Karen L Jones; Chinmay S Marathe
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-09       Impact factor: 5.555

8.  Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study.

Authors:  Y Iwamoto; A Kashiwagi; N Yamada; S Terao; N Mimori; M Suzuki; H Tachibana
Journal:  Diabetes Obes Metab       Date:  2010-08       Impact factor: 6.577

9.  Continuous versus bolus tube feeds: Does the modality affect glycemic variability, tube feeding volume, caloric intake, or insulin utilization?

Authors:  David C Evans; Rachel Forbes; Christian Jones; Robert Cotterman; Chinedu Njoku; Cattleya Thongrong; David Tulman; Sergio D Bergese; Sheela Thomas; Thomas J Papadimos; Stanislaw P Stawicki
Journal:  Int J Crit Illn Inj Sci       Date:  2016 Jan-Mar

10.  Compliance of checking HbA1c in a tertiary care hospital of Pakistan.

Authors:  Abdul Aziz; Syed Ahsan Ali
Journal:  Pak J Med Sci       Date:  2021 Jan-Feb       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.